Skip to main content

Are You Living With

Cutaneous Sarcoidosis?

You May Qualify for the BEACON Clinical Study.

Researchers are exploring a possible treatment option in adults diagnosed with cutaneous sarcoidosis.

You may qualify to take part in this study if you are living with the inflammatory effects of cutaneous sarcoidosis and are at least 18 years old.

About the BEACON Study

Researchers are testing a possible treatment option, called brepocitinib, in adults diagnosed with cutaneous sarcoidosis. They are evaluating the treatment’s safety, its effects on symptoms, and how the body responds over time.

What should I expect?

  1. 1. Screening
    (Up to 1 Month)

    First, you will have a screening visit to see whether you qualify. If you qualify and choose to participate, you will be in the study for a little over 1 year.

  2. 2. First Study Treatment Phase
    (About 16 Weeks)

    During the first phase, you will receive either the treatment option or a placebo (a look-alike tablet that does not contain active ingredients). This phase lasts about 4 months.

  3. 3. Second Study Treatment Phase
    (About 36 Weeks)

    During the second phase, all participants will receive the treatment. This phase lasts about 9 months.

  4. 4. Follow-Up
    (4 Weeks)

    About 1 month after taking your last dose of treatment, you will have a final series of medical tests.

  5. Throughout the study, you will have regular health assessments and check-ins with the research team.

  6. You will receive the investigational medicine or placebo and all study-related care at no cost. Participants who follow study requirements and complete study visits may be compensated and may also be reimbursed for study-related expenses, such as transportation, parking, and meals.

What is the investigational medicine?

The treatment is a tablet that is taken once a day. It is designed to decrease inflammation, which may help reduce the symptoms of cutaneous sarcoidosis. It has not yet been approved by any regulatory agency.

Do I Qualify?

Answer a few short questions to find out if you may qualify to take part in the BEACON study.

  • Are you at least 18 years old?
  • Have you been diagnosed with cutaneous sarcoidosis?
  • Do you have skin symptoms caused by sarcoidosis?

If you answered yes to these questions, you may qualify for this study. Please click the button below to complete the contact form and a study representative will be in touch.

Contact Me

Find a Study Site

Below is a list of locations for the BEACON Study.

U.S. Sites

  • New Hampshire

    Lebanon, NH

  • Massachusetts

    Burlington, MA

    Boston, MA

  • Rhode Island

    Providence, RI

  • Connecticut

    Farmington, CT

    New Haven, CT

  • New York

    Lake Success, NY

    Bronx, NY

  • Pennsylvania

    Philadelphia, PA

    Hershey, PA

  • Washington DC

    Washington, DC

  • Virginia

    Norfolk, VA

    Richmond, VA

    Roanoke, VA

  • Ohio

    Cleveland, OH

    Medina, OH

  • Michigan

    Ann Arbor, MI (2 sites)

  • North Carolina

    Durham, NC

  • Illinois

    Skokie, IL

    Chicago, IL

  • Indiana

    Indianapolis, IN

    Clarksville, IN

  • Minnesota

    Minneapolis, MN

    Medina, MN

  • Kentucky

    Louisville, KY

  • South Carolina

    Charleston, SC

  • Tennessee

    Smyrna, TN

  • Alabama

    Birmingham, AL

  • Missouri

    Lee's Summit, MO

  • Kansas

    Kansas City, KS

    Leawood, KS

  • Florida

    Miami, FL

  • Colorado

    Denver, CO

  • Texas

    Tyler, TX

    Prosper, TX

    Dallas, TX

    Pflugerville, TX

    Cedar Park, TX

    Austin, TX

  • Washington

    Mill Creek, WA

  • Utah

    Murray, UT

  • Oregon

    Portland, OR (2 sites)

  • Arizona

    Scottsdale, AZ

    Phoenix, AZ

  • California

    Sacramento, CA

    Oakland, CA

    San Francisco, CA

    Redwood City, CA

    Irvine, CA